Name: Keratosis Pilaris Treatment Market Analysis, Size, Share 2023-2030
Creator: DataM Intelligence
Published: Tue Oct 03 2023 12:03:57 GMT+0530 (India Standard Time)
License: https://www.datamintelligence.com/terms-conditions
Keywords: Keratosis Pilaris Treatment Market

Keratosis Pilaris Treatment Market Analysis, Size, Share 2023-2030

Keratosis Pilaris Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2>Keratosis Pilaris Treatment Market is segmented By Modality Type(Over-the-Counter and Prescription), By Treatment Type(Topical Exfoliates, Lotions, Cream and Others), Topical retinoids(Tretinoin (Atralin, Avita, Renova, and Retin-A), Tazarotene (Avage, Tazorac and Others), Laser treatment &nbsp;and Others), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2023-2030</h2>

<blockquote>
Keratosis Pilaris Treatment market size was valued USD&nbsp;million in 2022&nbsp;and is estimated to reach USD&nbsp;million by 2030, growing at a CAGR of 4.3 % during the forecast period (2023-2030).&nbsp;
</blockquote>

Keratosis pilaris is a common skin ailment that causes small bumps on your arms, legs, or buttocks. Bumps form when there is too much keratin in your skin. Moisturizers and prescription creams are used to assist and improve the appearance of the skin. By the age of 30, the problem normally goes away.

As per DataM Intelligence, Keratosis Pilaris Treatment market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation. It also provides global Keratosis Pilaris Treatment market size, and growth, along with the latest trends, opportunities, and forecast till 2029 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.

Among all regions, the North American region is expected to hold the largest share of the global market over the forecast period. Keratosis Pilaris Treatment market in the United States and Canada produces the utmost share. Whereas the European Keratosis Pilaris Treatment market is projected to continue its presence globally during the period of 2022- 2029.

<h3>Market Scope</h3>

<table border="1" cellpadding="1" cellspacing="1">
	<tbody>
		<tr>
			<td>
			Metrics
			</td>
			<td>
			Details
			</td>
		</tr>
		<tr>
			<td>
			Market&nbsp;CAGR
			</td>
			<td>
			4.3%
			</td>
		</tr>
		<tr>
			<td>
			Segments Covered
			</td>
			<td>
			By Modality Type,&nbsp;By Treatment Type,&nbsp;By Distribution Channel,&nbsp;and By Region
			</td>
		</tr>
		<tr>
			<td>
			Report Insights Covered
			</td>
			<td>
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
			</td>
		</tr>
		<tr>
			<td>
			Fastest Growing Region
			</td>
			<td>
			Asia Pacific
			</td>
		</tr>
		<tr>
			<td>
			Largest Market Share&nbsp;
			</td>
			<td>
			North America
			</td>
		</tr>
	</tbody>
</table>

To know more insights into Market, Get Our <a href="https://www.datamintelligence.com/download-sample/keratosis-pilaris-treatment-market">Sample Brochure</a>

&nbsp;

<h3>Market Dynamics</h3>

Advancement in the treatment of Keratosis Pilaris is expected to drive market growth.

Chlorine dioxide compound is a great antibacterial and anti-inflammatory substance that is non-toxic to humans. It&#39;s a dangerous gas at high concentrations. Still, when it&#39;s dissolved in water and administered to human tissue, it&#39;s inactivated by an intracellular defense mechanism, so there are no adverse effects. In keratosis pilaris, it has been discovered to be an effective cleansing agent. Moreover, it functions as a keratolytic by neutralizing reactive oxygen molecules and destroying the intramolecular and intermolecular disulfide bonds that stabilize keratin. It only reacts with a few specific amino acids and does not oxidize lipids, carbohydrates, or other organic compounds. Cysteine, tyrosine, tryptophan, methionine, proline, hydroxyproline, and histidine are among the amino acids it reacts with, with cysteine, methionine, tyrosine, and tryptophan constituting the majority of its biologic action. Therefore, there is an increased demand for the treatment of Keratosis Pilaris. Thus, from the above statements, the market is expected to drive in the forecast period.

Complications associated with Keratosis Pilaris Treatment are expected to hamper the market growth.

Patients are often distressed about the cosmetic appearance of the condition. Scarring resulting from the patient rupturing the lesions traumatically is another problem that might occur. Lack of awareness about the importance of using the prescribed topical treatments and not manipulating the lesions are some factors the market is expected to hamper in the forecast period.&nbsp;

<h3>Industry Analysis</h3>

The keratosis pilaris treatment market provides in-depth analysis of the market based on various industry factors such as porter&rsquo;s five forces, supply chain analysis, reimbursement scenario, product innovation, pricing analysis, etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. SARS-CoV-2-related cutaneous diseases have been on the rise all over the world. Maculopapular rash, vesicular rash, pseudo-chilblain, keratosis pilaris, and urticaria are the five most common patterns associated with these disorders. Moreover, due to limits on non-essential doctor visits and complete lockdown in most countries, diagnosis and treatment rates have decreased dramatically by 2020. In addition, the American Academy of Dermatology was in constant contact with dermatologists to limit the number of patients with non-urgent medical concerns, such as keratosis pilaris, who were allowed to visit.

Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of the economic activities.

<h3>Segment Analysis</h3>

Topical Exfoliates segment is expected to hold the largest market share in keratosis pilaris treatment market

The topical exfoliates segment is expected to dominate in 2021. The segment is beneficial because Keratosis pilaris normally disappears on its own over time. In the interim, you can improve the appearance of your skin using any of the many products available. If moisturizing and other self-care measures don&#39;t help, your doctor may prescribe medicated creams. For instance, Alpha hydroxy acid, lactic acid, salicylic acid, and urea-containing creams help loosen and eliminate dead skin cells. They also soften and hydrate dry skin. These creams (topical exfoliants) are available over-the-counter or with a prescription, depending on their intensity.

Moreover, the use of a medicated cream daily may help to improve the appearance of the skin. If you stop, though, the problem will return. Keratosis pilaris can linger for years, even after treatment. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

<h3>Geographical Analysis</h3>

North America region holds the largest market share in the global keratosis pilaris Treatment market

In 2021, North America accounted for the highest revenue share. The increasing prevalence of Keratosis Pilaris, rising patient education among the population, advancement in the treatment of Keratosis Pilaris, high rate of adoption of solutions, increase in the number of patients with keratosis pilaris visiting the doctor, as well as new players are focusing on forming partnerships with pharmacies are some of the factors the market is expected to boost in the forecast period. For instance, The appropriate management of keratosis pilaris necessitates patient education. Patients must recognize that keratosis pilaris is a chronic illness with no cure. The physician should also inform the patient that the illness often improves without therapy over time and that treatments are purely cosmetic. Patients must understand that keratosis pilaris is frequently resistant to treatment methods.

Moreover, Keratosis pilaris causes discoloration, which can be improved with laser treatments. Laser treatments are performed by dermatologists who use a laser to target the skin. It&#39;s sometimes used to alleviate extreme inflammation and redness. It&#39;s not a cure, but it might help when creams and lotions aren&#39;t cutting it. This treatment requires numerous sessions to be effective. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

<h3>Competitive Landscape</h3>

Major key players in the keratosis pilaris treatment market are Neostrata Company, Inc., SLMD Skincare, Galderma, Touch Skin Care, Nip + Fab, Neutrogena, Eucerin, AmLactin, CeraVe, First Aid Beauty.&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Neostrata Company, Inc.:

Overview:

NeoStrata Company, Inc., located in Princeton, NJ, develops and markets a comprehensive range of clinically proven, dermatologist-developed skincare brands, including NeoStrata, Exuviance, CoverBlend, NeoCeuticals and NeoStrata Therapeutics. Polyhydroxy Acid technology is used in the company&#39;s innovative therapeutic and aesthetic dermatological solutions to fulfill the needs of all skin types. They&#39;re sold at consumer stores, doctors&#39; clinics, and spas worldwide. Moreover, AHAs are advantageous in treating dermatological diseases and efficient in spurring prematurely aged or damaged skin to regenerate itself, revolutionizing the treatment of aging skin, according to the company&#39;s passion and vision.

&shy;Product Portfolio:

GLYCOLIC RENEWAL SERUM: This potent blend of 10% Alpha Hydroxy Acid (AHA) and antioxidants is designed to improve the texture of the skin&#39;s surface. Glycolic Acid is formulated to promote surface skin cells&#39; exfoliation while keeping the pH at a healthy level.

The global keratosis pilaris treatment market report would provide an access to an approx. 45+market data table, 40+figures and 160pages.

<ol>
	<li>Methodology and Scope
	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>Market Definition and Overview</li>
	<li>Executive Summary</li>
	<li>Market Dynamics
	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Advancement in the treatment of Keratosis Pilaris is expected to drive market growth.</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>Complications associated with Keratosis Pilaris Treatment are expected to hamper the market growth.</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Industry Analysis
	<ol>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Unmet Needs</li>
	</ol>
	</li>
	<li>COVID-19 Analysis
	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>By Modality Type
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type</li>
			<li>Market Attractiveness Index, By Modality Type Segment</li>
		</ol>
		</li>
		<li>Over-the-Counter*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li>
		</ol>
		</li>
		<li>Prescription</li>
	</ol>
	</li>
	<li>By Treatment Type
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Attractiveness Index, By Treatment Type Segment</li>
		</ol>
		</li>
		<li>Topical Exfoliates*
		<ol>
			<li>Lotions</li>
			<li>Cream</li>
			<li>Others</li>
		</ol>
		</li>
		<li>Topical retinoids
		<ol>
			<li>Tretinoin (Atralin, Avita, Renova, and Retin-A)</li>
			<li>Tazarotene (Avage, Tazorac)</li>
			<li>Others</li>
		</ol>
		</li>
		<li>Laser treatment</li>
		<li>Others</li>
	</ol>
	</li>
	<li>By Distribution Channel
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Attractiveness Index, By Distribution Channel Segment</li>
		</ol>
		</li>
		<li>Hospital Pharmacies*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029</li>
		</ol>
		</li>
		<li>Retail Pharmacies</li>
		<li>Online Pharmacies</li>
		<li>Others</li>
	</ol>
	</li>
	<li>By Region
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Competitive Landscape
	<ol>
		<li>Key Developments and Strategies</li>
		<li>Company Share Analysis</li>
		<li>Product Benchmarking</li>
		<li>List of Key Companies to Watch</li>
	</ol>
	</li>
	<li>Company Profiles
	<ol>
		<li>Neostrata Company, Inc.*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview &nbsp;</li>
		</ol>
		</li>
		<li>SLMD Skincare&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>Galderma&nbsp;&nbsp;&nbsp;</li>
		<li>Touch Skin Care&nbsp;&nbsp;</li>
		<li>Nip + Fab&nbsp;&nbsp;&nbsp;</li>
		<li>Neutrogena</li>
		<li>Eucerin&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>AmLactin&nbsp;&nbsp;&nbsp;</li>
		<li>CeraVe&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
		<li>First Aid Beauty(*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>DataM Intelligence
	<ol>
		<li>Appendix</li>
		<li>About Us and Applications</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table1 Global Keratosis Pilaris Treatment Market Value, By Modality Type, 2022, 2026 &amp; 2030 ($ Million)

Table2 Global Keratosis Pilaris Treatment Market Value, By Treatment Type, 2022, 2026 &amp; 2030 ($ Million)

Table3 Global Keratosis Pilaris Treatment Market Value, By Distribution Channel, 2022, 2026 &amp; 2030 ($ Million)

Table4 Global Keratosis Pilaris Treatment Market Value, By Region, 2022, 2026 &amp; 2030 ($ Million)

Table5 Global Keratosis Pilaris Treatment Market Value, By Modality Type, 2022, 2026 &amp; 2030 ($ Million)

Table6 Global Keratosis Pilaris Treatment Market Value, By Modality Type, 2021-2030 ($ Million)

Table7 Global Keratosis Pilaris Treatment Market Value, By Treatment Type, 2022, 2026 &amp; 2030 ($ Million)

Table8 Global Keratosis Pilaris Treatment Market Value, By Treatment Type, 2021-2030 ($ Million)

Table9 Global Keratosis Pilaris Treatment Market Value, By Distribution Channel, 2022, 2026 &amp; 2030 ($ Million)

Table10 Global Keratosis Pilaris Treatment Market Value, By Distribution Channel, 2021-2030 ($ Million)

Table11 Global Keratosis Pilaris Treatment Market Value, By Region, 2022, 2026 &amp; 2030 ($ Million)

Table12 Global Keratosis Pilaris Treatment Market Value, By Region, 2021-2030 ($ Million)

Table13 North America Keratosis Pilaris Treatment Market Value, By Modality Type, 2021-2030 ($ Million)

Table14 North America Keratosis Pilaris Treatment Market Value, By Treatment Type, 2021-2030 ($ Million)

Table15 North America Keratosis Pilaris Treatment Market Value, By Distribution Channel, 2021-2030 ($ Million)

Table16 North America Keratosis Pilaris Treatment Market Value, By Country, 2021-2030 ($ Million)

Table17 South America Keratosis Pilaris Treatment Market Value, By Modality Type, 2021-2030 ($ Million)

Table18 South America Keratosis Pilaris Treatment Market Value, By Treatment Type, 2021-2030 ($ Million)

Table19 South America Keratosis Pilaris Treatment Market Value, By Distribution Channel, 2021-2030 ($ Million)

Table20 South America Keratosis Pilaris Treatment Market Value, By Country, 2021-2030 ($ Million)

Table21 Europe Keratosis Pilaris Treatment Market Value, By Modality Type, 2021-2030 ($ Million)

Table22 Europe Keratosis Pilaris Treatment Market Value, By Treatment Type, 2021-2030 ($ Million)

Table23 Europe Keratosis Pilaris Treatment Market Value, By Distribution Channel, 2021-2030 ($ Million)

Table24 Europe Keratosis Pilaris Treatment Market Value, By Country, 2021-2030 ($ Million)

Table25 Asia-Pacific Keratosis Pilaris Treatment Market Value, By Modality Type, 2021-2030 ($ Million)

Table26 Asia-Pacific Keratosis Pilaris Treatment Market Value, By Treatment Type, 2021-2030 ($ Million)

Table27 Asia-Pacific Keratosis Pilaris Treatment Market Value, By Distribution Channel, 2021-2030 ($ Million)

Table28 Asia-Pacific Keratosis Pilaris Treatment Market Value, By Country, 2021-2030 ($ Million)

Table29 Middle East &amp; Africa Keratosis Pilaris Treatment Market Value, By Modality Type, 2021-2030 ($ Million)

Table30 Middle East &amp; Africa Keratosis Pilaris Treatment Market Value, By Treatment Type, 2021-2030 ($ Million)

Table31 Middle East &amp; Africa Keratosis Pilaris Treatment Market Value, By Distribution Channel, 2021-2030 ($ Million)

Table32 Neostrata Company, Inc.: Overview

Table33 Neostrata Company, Inc.: Product Portfolio

Table34 Neostrata Company, Inc.: Key Developments

Table35 SLMD Skincare: Overview

Table36 SLMD Skincare: Product Portfolio

Table37 SLMD Skincare: Key Developments

Table38 Galderma: Overview

Table39 Galderma: Product Portfolio

Table40 Galderma: Key Developments

Table41 Touch Skin Care: Overview

Table42 Touch Skin Care: Product Portfolio

Table43 Touch Skin Care: Key Developments

Table44 Nip + Fab: Overview

Table45 Nip + Fab: Product Portfolio

Table46 Nip + Fab: Key Developments

Table47 Neutrogena: Overview

Table48 Neutrogena: Product Portfolio

Table49 Neutrogena: Key Developments

Table50 Eucerin: Overview

Table51 Eucerin: Product Portfolio

Table52 Eucerin: Key Developments

Table53 AmLactin: Overview

Table54 AmLactin: Product Portfolio

Table55 AmLactin: Key Developments

Table56 CeraVe: Overview

Table57 CeraVe: Product Portfolio

Table58 CeraVe: Key Developments

Table59 First Aid Beauty: Overview

Table60 First Aid Beauty: Product Portfolio

Table61 First Aid Beauty: Key Developments

List of Figures

Figure1 Global Keratosis Pilaris Treatment Market Share, By Modality Type, 2022 &amp; 2030 (%)

Figure2 Global Keratosis Pilaris Treatment Market Share, By Treatment Type, 2022 &amp; 2030 (%)

Figure3 Global Keratosis Pilaris Treatment Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure4 Global Keratosis Pilaris Treatment Market Share, By Region, 2022 &amp; 2030 (%)

Figure5 Global Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure6 Global Keratosis Pilaris Treatment Market Y-o-Y Growth, By Modality Type, 2020-2028 (%)

Figure7 Over-the-Counter: Global Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure8 Prescription: Global Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure9 Global Keratosis Pilaris Treatment Market Y-o-Y Growth, By Treatment Type, 2020-2028 (%)

Figure10 Topical Exfoliates: Global Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure11 Topical retinoids: Global Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure12 Laser treatment: Global Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure13 Others: Global Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure14 Global Keratosis Pilaris Treatment Market Y-o-Y Growth, By Distribution Channel, 2020-2028 (%)

Figure15 Hospital Pharmacies: Global Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure16 Retail Pharmacies: Global Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure17 Online Pharmacies: Global Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure18 Others: Global Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure19 Global Keratosis Pilaris Treatment Market Y-o-Y Growth, By Region, 2020-2028 (%)

Figure20 North America Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure21 North America Keratosis Pilaris Treatment Market Share, By Modality Type, 2022 &amp; 2030 (%)

Figure22 North America Keratosis Pilaris Treatment Market Share, By Treatment Type, 2022 &amp; 2030 (%)

Figure23 North America Keratosis Pilaris Treatment Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure24 North America Keratosis Pilaris Treatment Market Share, By Country, 2022 &amp; 2030 (%)

Figure25 South America Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure26 South America Keratosis Pilaris Treatment Market Share, By Modality Type, 2022 &amp; 2030 (%)

Figure27 South America Keratosis Pilaris Treatment Market Share, By Treatment Type, 2022 &amp; 2030 (%)

Figure28 South America Keratosis Pilaris Treatment Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure29 South America Keratosis Pilaris Treatment Market Share, By Country, 2022 &amp; 2030 (%)

Figure30 Europe Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure31 Europe Keratosis Pilaris Treatment Market Share, By Modality Type, 2022 &amp; 2030 (%)

Figure32 Europe Keratosis Pilaris Treatment Market Share, By Treatment Type, 2022 &amp; 2030 (%)

Figure33 Europe Keratosis Pilaris Treatment Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure34 Europe Keratosis Pilaris Treatment Market Share, By Country, 2022 &amp; 2030 (%)

Figure35 Asia-Pacific Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure36 Asia-Pacific Keratosis Pilaris Treatment Market Share, By Modality Type, 2022 &amp; 2030 (%)

Figure37 Asia-Pacific Keratosis Pilaris Treatment Market Share, By Treatment Type, 2022 &amp; 2030 (%)

Figure38 Asia-Pacific Keratosis Pilaris Treatment Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure39 Asia-Pacific Keratosis Pilaris Treatment Market Share, By Country, 2022 &amp; 2030 (%)

Figure40 Middle East &amp; Africa Keratosis Pilaris Treatment Market Value, 2021-2030 ($ Million)

Figure41 Middle East &amp; Africa Keratosis Pilaris Treatment Market Share, By Modality Type, 2022 &amp; 2030 (%)

Figure42 Middle East &amp; Africa Keratosis Pilaris Treatment Market Share, By Treatment Type, 2022 &amp; 2030 (%)

Figure43 Middle East &amp; Africa Keratosis Pilaris Treatment Market Share, By Distribution Channel, 2022 &amp; 2030 (%)

Figure44 Neostrata Company, Inc.: Financials

Figure45 SLMD Skincare: Financials

Figure46 Galderma: Financials

Figure47 Touch Skin Care: Financials

Figure48 Nip + Fab: Financials

Figure49 Neutrogena: Financials

Figure50 Eucerin: Financials

Figure51 AmLactin: Financials

Figure52 CeraVe: Financials

Figure53 First Aid Beauty: Financials